14.06.2019 - 09:00h

Novel Concepts in Niche-directed Cancer Therapies

From June 13th to June 14th 2019, the Georg-Speyer-Haus will host the Symposium

Novel Concepts in...

31.05.2019 - 12:30h

Radial organization of the genome revealed by GPSeq / DNA barcoding and linear amplification in single-cell sequencing in research and diagnostics

Magda Bienko, PhD and Nicola Crosetto, MD/PhD, Karolinska Institute, Stockholm

07.05.2019 - 12:30h

Using DNA methylation data to study the tumour microenvironment

Dr. Tim Fenton, Lecturer in Molecular Biosciences, University of Kent, UK

20.03.2019 - 15:30h

The HEROS story, and perspectives on rational engineering of effective CAR molecules

Dr. Nabil Ahmed, Associate Professor, Department of Pediatrics, Baylor College of Medicine, Housten TX, USA

26.02.2019 - 12:30h

Genomic Landscape of Small Cell Lung Cancer and other Neuroendocrine Lung Tumor

Dr. Julie George, University of Cologne, Department of Translational Genomics

31.01.2019 - 15:30h

Divide and Conquer: Classification in cancer systems analysis

Dr. Elke Markert, Institute for Cancer Sciences, University of Glasgow, UK

24.01.2019 - 15:30h

Decomposing Intra Tumor Heterogeneity

Dr. Ruping Sun, Curtis Lab, Departments of Medicine and Genetics, Stanford University, USA

22.11.2018 - 15:30h

The molecular signatures of murine B cell acute lymphoblastic leukemia model

Dr. Senthilkumar Ramamoorthy, Max Planck Institute of Immunobiology and Epigenetics, Freiburg

15.11.2018 - 15:30h

Systems biology for precision microbiome engineering and immune system modulation

Dr. Richard Stein, Dana-Farber Cancer Institute, Boston, USA

19.10.2018 - 15:30h

Exploiting the heterogeneity of mutant Kras lung tumours for improved targeting

Dr. Carla Martins, MRC Cancer Unit, University of Cambridge, UK

17.10.2018 - 11:00h

Single cell analysis reveals Notch as a mediator of secondary senescence

Dr. Tamir Chandra, MRC Institute of Genetics & Molecular Medicine, University of Edinburgh, UK

15.10.2018 - 14:00h


Dr. Amit Kumar, Indian Institute of Toxicology Research, CSIR-IITR, Lucknow, India

29.08.2018 - 15:30h

The global landscape of DNA damage repair networks and the CBP/p300-regulated acetylome

Prof. Dr. Chuna Choudhary, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, DK

10.07.2018 - 15:30h

"Protozoan trigger of chronic intestinal inflammation"

Professor Dr. Lars Eckmann, University of California, San Diego, USA

28.06.2018 - 15:30h

Immune biological rationale for the design of radioimmunotherapies

Prof. Dr. rer. nat. habil. Udo Gaipl, Universitätsklinikum Erlangen, Leiter Strahlen-Immunbiologie

14.06.2018 - 15:30h

Elucidating the role of mutant IDH in gliomagenesis

Dr. Sevin Turcan, Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

13.06.2018 - 11:00h

Chromatin as nexus between basic and applied research - focus on histone variants and leukaemia

Dr. Marcus Buschbeck, Josep Carreras Leukaemia Research Institute, Barcelona, Spain

07.06.2018 - 15:30h

Protein and transcript turnover as regulators of cell fate

Prof. Dr. Andre Catic, Baylor College of Medicine, Houston, TX

06.06.2018 - 15:00h

Cell-specific functions of EGFR in inflammation and cancer

Professor Dr. Maria Sibilia, Institute of Cancer Research, Medical University of Vienna, Austria

15.03.2018 - 15:30h

The contact system at the crosstalk of coagulation, inflammation and innate immunity

Prof. Dr. Dr. Thomas Renné, Institut für Klinische Chemie und Laboratoriumsmedizin, Zentrum für Diagnostik, Universitätsklinikum Hamburg-Eppendorf

08.03.2018 - 15:30h

Targeting Autophagy and Metabolic Dependencies in Leukaemic Stem Cells

Dr. Vignir Helgason, Institute of Cancer Sciences, University of Glasgow

12.02.2018 - 16:00h

Understanding Gene Regulation

Dr. Michaela Willi, National Institutes of Health, Bethesda

01.02.2018 - 15:30h

Dissecting the cellular and molecular mechanisms in the pathogenesis of bone marrow fibrosis

Prof. Dr. Rebekka Schneider-Kramann, Erasmus MC, Rotterdam

11.01.2018 - 15:30h

The impact of infection and inflammation analyzed on single cell, organ and organismal level

Prof. Dr. Matthias Gunzer, Institut für Experimentelle Immunologie und Bildgebung, Universität Duisburg-Essen

23.11.2017 - 15:30h

"Acute myeloid leukemia associated alteration of the bone marrow microenvironment"

Dr. Diana Passaro, Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, London

09.11.2017 - 15:30h

"Expanding the CRISPR Toolbox with 3Cs-gRNAs"

Dr. Manuel Kaulich, Institut Biochemie II, Universitätsklinikum Frankfurt

05.10.2017 - 15:30h

“A Highly Specific Inhibitor Targeting the Effector Binding Site of Ras”

Dr. Andreas Ernst, Institut Biochemie II, Universitätsklinikum Frankfurt

28.09.2017 - 15:30h

“Metabolism, metabolites and endothelial plasticity”

PD Dr. Michael Potente, Max Planck Institute for Heart and Lung Research, Bad Nauheim

18.09.2017 - 15:00h

"The onco-metabolic role and liabilities of the TCA cycle in cancer"

Prof. Eyal Gottlieb, Technion-Israel Institute of Technology Haifa, Israel

07.09.2017 - 15:30h

"Tumour Microenvironment Triggers Neuroblastoma Cell Migration and Invasion"

Dr. Olga Piskareva, Molecular & Cellular Therapeutics (MCT), Royal College of Surgeons in Ireland RCSI

25.08.2017 - 11:00h

”CRISPR screening with single-cell transcriptome readout establishes a high-throughput method for dissecting gene-regulatory mechanisms”

Prof. Dr. Christoph Bock, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna

13.07.2017 - 15:30h

"Malignant alterations of the human bone marrow microenvironment"

PD Dr. Manja Wobus, Universitätsklinikum Carl Gustav Carus, Dresden, Stem Cell Lab

06.07.2017 - 15:30h

“Mechanisms of immune evasion and metastasis in colorectal cancer”

Dr. Eduard Batlle, ICREA Research Professor, Institute for Research in Biomedicine (IRB Barcelona), Spanien

08.06.2017 - 15:30h

"G-quadruplex DNA revolution in cancer research: A novel biomarker for tracking cancer gene activity and genome instability"

Dr. Robert Hänsel-Hertsch, Cancer Research UK, Cambridge Institute, Li Ka Shing Centre

31.05.2017 - 18:15h

“Beyond Targeting Oncogenes: Emerging Anti-Cancer Strategies”

Professor Dr. Tak W. Mak, University Health Networks, Princess Margaret Cancer Center, Toronto, Canada

17.05.2017 - 15:30h

“The role of the transcription factor and epigenetic modulator NFE2 in myeloproliferative neoplasms”

Prof. Dr. Heike L. Pahl, Center for Tumor Biology, University Hospital Freiburg

06.04.2017 - 15:30h

“Dual role of chromosome instability in cancer”

Prof. Dr. Rocio Sotillo, Molecular Thoracic Oncology, German Cancer Research Center (DKFZ)

30.03.2017 - 15:30h

"The Power of Single Cells: BD Genomics Integrated Workflow to Gene Expression Studies"

Dr. Wieland Keilholz, BD Life Sciences Genomics, Heidelberg

23.03.2017 - 15:30h

"Regulation and Heterogeneity of Dormant Hematopoietic Stem Cells"

Dr. Nina Cabezas-Wallscheid, Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg

02.03.2017 - 15:30h

„Novel Targeted Therapies in T-Cell Acute Lymphoblastic Leukemia“

Prof. Dr. Jacques Ghysdael, Institut Curie, Paris

02.02.2017 - 15:30h

"Targeting treatment-resistant leukemia in preclinical mouse models"

Prof. Dr. med. Irmela Jeremias, Helmholtz Zentrum München

19.01.2017 - 15:30h

"Use of a fungal toxin to unravel the intracellular signaling pathway of anoikis (detachment-induced apoptosis)“

Prof. Dr. Dr. h.c. Christoph Borner, Institute of Molecular Medicine and Cell Research, University of Freiburg

10.01.2017 - 11:00h

"FUBP1: one more evidence as a player in hematological lineages“

Dr. Marie-Bérengère Troadec, Institute of Genetics and Development of Rennes, Université de Rennes

06.12.2016 - 18:15h

"RIP kinase 1 in the regulation of cell death, inflammation and cancer"

Prof. Dr. Manolis Pasparakis, Institute for Genetics, University of Cologne, Cologne

09.11.2016 - 17:00h

"Cellular senescence in cancer - therapeutic goal or not?"

Prof. Dr. med. Clemens A. Schmitt, Charité - Universitätsmedizin Berlin (CVK), and Max-Delbrück-Center for Molecular Medicine

27.10.2016 - 15:30h

"Adenovirus expressed liver autoantigen (CYP2D6) induces chronic autoimmune hepatitis in wild type mice"

Prof. Dr. Urs Christen, Pharmazentrum Frankfurt, Klinikum der Goethe Universität Frankfurt

20.10.2016 - 15:30h

“Discovery of a new bacterial species in a dysbiotic human gut microbiome”

Dr. Falk Hildebrand, European Molecular Biology Laboratory (EMBL), Heidelberg

12.10.2016 - 18:15h

"The Pathogenic Role of Defective Endosomal-Lysosomal Function in Alzheimer's Disease"

Professor Ralph Nixon, NYU School of Medicine, New York

01.09.2016 - 17:00h

"Publishing your work - a Cell editor's perspective"

Elena Porro, Cell Press, Cambridge, MA, USA

02.06.2016 - 15:30h

"Anti-TNF in Crohn's disease, targeted therapy or lucky shot?"

Professor Gijs R. van den Brink, M.D., Ph.D., Academic Medical Center, Amsterdam

01.06.2016 - 18:15h

»Metastatic Colonization by Circulating Tumor Cells«

Professor Dr. Joan Massagué, Memorial Sloan Kettering Cancer Center, NY, USA

11.05.2016 - 16:00h

Polo kinases from centrosome duplication to mitotic controls

Dr. Kyung Lee, National Cancer Institute, Bethesda

21.04.2016 - 15:30h

The Mdm2 oncoprotein as a modulator of chromatin dynamics

Prof. Dr. Matthias Dobbelstein, Institute of Molecular Oncology, University of Göttingen

10.03.2016 - 15:30h

CRISPR/Cas9 in action: a Cdk4-dependent phosphorylation threshold regulates the cell cycle entry decision

Dr. Manuel Kaulich, Institute for Biochemistry II, Goethe Universität Frankfurt

02.03.2016 - 16:00h

Pathologie of cell death

Univ.-Prof. Dr. Wilfried Roth, Institute for Pathology, Johannes Gutenberg-Universität Mainz

18.02.2016 - 15:30h

Good Scientific Practice in Flow Cytometry: Pitfalls in Acquisition and Analysis

Dr. Steffen Schmitt, German Cancer Research Center (DKFZ), Heidelberg

28.01.2016 - 15:30h

Cell fate reprogramming in pancreatic cancer

Prof. Dr. Axel Behrens, Cancer Research, The Francis Crick Institute, UK

21.01.2016 - 15:30h

Functional approaches to understanding intestinal stem cells

Dr. Doug Winton, Cancer Research Institute, University of Cambridge, UK

14.01.2016 - 15:30h

T cell: myeloid cell interactions in autoimmunity

Prof. Dr. Burkhard Becher, Universität Zürich

19.11.2015 - 15:30h

Growth factors, Nutrients and Cancer

Dr. Nabil Djouder, CNIO Madrid

22.10.2015 - 15:30h

Novel technologies for mapping of immune reactivity against cancer

Dr. Sine Reker Hadrup, Technical University of Denmark

15.10.2015 - 15:30h

Fences make good neighbors: staying out of your neighbors genetic yard

Dr. Kyung Hyun Ryu, National Institutes of Health (NIH) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, USA

02.10.2015 - 15:00h

Mass spectrometry-based proteomics: Current status and future perspective

Dr. Thomas Oellerich, Universitätsklinikum Frankfurt

01.10.2015 - 15:30h

Neural regulation of the leukemic stem cell niche

Dr. Maher Hanoun, Klinik für Hämatologie, Universitätsklinik Essen

25.09.2015 - 14:00h

Pim-1 kinase activity as drug target for cancer therapy

Dr. Oliver Renner, Spanish National Cancer Research Centre (CNIO), Madrid

03.09.2015 - 15:30h

Programmed cell death in the intestinal epithelium and liver

Dr. Claudia Günther, Friedrich-Alexander-Universität, Erlangen

25.06.2015 - 15:30h

Priming for stem cell like traits and epithelial plasticity by transient activation of Twist1

Dr. Christina Scheel, Helmholtz-Zentrum München

29.05.2015 - 14:00h

Role of Gfi1 in leukemia

Dr. med. Cyrus Khandanpour, Universitätsklinikum Essen

28.05.2015 - 15:00h

A systems biological perspective on the organization of hematopoietic stem cells

Prof. Dr. Ingo Röder, Faculty of Medicine Carl Gustav Carus, TU Dresden

30.04.2015 - 15:00h

Targeting epigenetic effector domains of the bromodomain family in cancer

Dr. Stefan Knapp, Goethe-Universität, Institut für Pharmazeutische Chemie

16.04.2015 - 15:30h

Mass spectrometry based immunopeptidomics - from discoveries to therapies

Dr. Michal Bassani-Sternberg, Max-Planck-Institute of Biochemistry, Martinsried

09.04.2015 - 15:00h

Targeting HOX Gene Expression in Acute Myeloid Leukemia

Dr. Michael Kühn, Memorial Sloan Kettering Cancer Center, New York

13.03.2015 - 15:00h

Immune checkpoint blockade in cancer therapy: New insights, opportunities and prospects for a cure

Prof. Dr. James P. Allison, The University of Texas Anderson Cancer Center, Houston, USA

12.03.2015 - 15:30h

Modular strategies for redirecting immune effector cells

Prof. Dr. Michael Bachmann, Helmholtz Zentrum Dresden Rossendorf and University Cancer Center (UCC) TU Dresden

03.03.2015 - 09:00h

Net4CGD, 2nd Annual Meeting

Various Speakers

12.02.2015 - 15:30h

A rude awakening: exit from dormancy drives hematopoietic stem cell attrition and eventual bone marrow failure

Dr. Michael Milson, HI-STEM gGmbH im Deutschen Krebsforschungszentrum (DKFZ), Heidelberg

05.02.2015 - 15:30h

Direct production of mouse mutants using ZFNs, TALENs or Crispr/Cas in one-cell embryos

Dr. Ralf Kühn, Max-Delbrück-Centrum für Molekulare Medizin

29.01.2015 - 15:30h

Genes, environment & microbiota: Does ER stress convert autophagy defects into Crohn's disease?

Prof. Dr. med. Arthur Kaser, University of Cambridge

23.01.2015 - 14:30h

Broad Spectrum CAR T cells for Solid Tumor Immunotherapy

Dr. Nabil M. Ahmed, Baylor College of Medicine, Houston

22.01.2015 - 15:30h

IRF1 dictates the IL-21 dependent anticancer functions of Th9 cells

Dr. Francois Ghiringhelli, INSERM U866 and Centre Georges-Francois Leclerc, Dijon

15.01.2015 - 15:30h

Function of flotillins in cellular signaling and membrane trafficking

Prof. Dr. Ritva Tikkanen, Universität Gießen

18.12.2014 - 15:30h

Murine models with transposon-induced resectable tumors for experimental therapy

Dr. Engin Guerlevik, Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover

11.12.2014 - 10:15h

Stem Cell Aging and Cancer

Prof. Dr. Karl Lenhard Rudolph, Leibniz Institut für Altersforschung, Jena

20.11.2014 - 15:30h

A limited niche controls boom-and-boost pattern of adult neural stem cell dynamics

Dr. Onur Basak, Hubrecht Institute, Royal Netherlands Academy of Arts and Science, Utrecht

13.11.2014 - 17:30h

The role of the intestinal immune system in GvHD

Prof. Dr. Robert Zeiser, Universitätsklinikum Freiburg

09.10.2014 - 15:30h

JAK-STAT-signaling in leukemia and NK cell mediated tumor surveillance

Prof. Dr. Veronika Sexl, University of Veterinary Medicine, Vienna

08.10.2014 - 17:30h

Autophagy in haematological tumors

Dr. Katharina Simon, University of Oxford, UK

26.09.2014 - 15:00h

Gp-130-Stat3-signaling: A rheostat for the intestinal epithelium?

Prof. Dr. Matthias Ernst, Walter and Eliza Hall Institute of Medical Research (WEHI), Melbourne, Australia

25.09.2014 - 15:30h

Thrombopoietin/Mpl Signaling and the genetic modification of HSC

Prof. Dr. Ute Modlich, Paul-Ehrlich-Institut, Langen

22.09.2014 - 15:30h

The regulation of T Follicular Helper cells

Prof. Dr. Cecile King, The Garvan Institute for Medical Research, Sydney, Australia

22.08.2014 - 11:00h

Epigenetic regulation of gene expression in castration resistent prostate cancer cells

Dr. Anna Groner, Dana Farber Cancer Institute and Harvard Medical School Boston MA, USA

21.07.2014 - 15:30h

Caspase-8 and intestinal homeostasis

Prof. Dr. Lars Eckmann, University of California, San Diego

17.07.2014 - 15:30h

Activation and differentiation of human group 3 innate lymphoid cells (ILC)

Dr. Chiara Romagnani, Deutsches Rheuma-Forschungszentrum Berlin

10.07.2014 - 15:30h

Development and function of innate lymphoid cells

Prof. Dr. Andreas Diefenbach, Universitätsklinikum Johannes Gutenberg-Universität Mainz

07.07.2014 - 15:30h

Title to be announced

Dr. Hind Medyouf, DKFZ Heidelberg

03.07.2014 - 15:30h

JAK STAT signaling in leukemia and NK cell mediated tumor surveillance

Prof. Dr. med. univ. Veronika Sexl, University of Veterinary Medicine Vienna

05.06.2014 - 15:30h

3D in vitro models for tumor stroma interaction

Prof. Dr. Margareta Müller, BME Fakultät MLS Villingen-Schwenningen

22.05.2014 - 15:30h

Cancer cell- and stroma-derived lysosomal proteases in invasive growth and metastasis of mammary cancer in mice

Prof. Dr. Thomas Reinheckel, Universitätsklinikum Freiburg

21.05.2014 - 01:00h

T cells as therapeutics for solid tumors: Armed and ready to go?

Description: Prof. Dr. Stephen Gottschalk Baylor College of Medicine, Houston

15.05.2014 - 15:30h

Epigenetic regulation by histone 3 lysine 4 methyltransferases in development and cancer

Description: Prof. Francis Stewart
Genomics Technische Universitaet Dresden

08.05.2014 - 15:30h

Mechanisms of NK cell activation in cutaneous and visceral leishmaniasis

Description: Prof. Dr. Christian Bogdan
Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg

05.05.2014 - 15:30h

Tumor-stroma interactions in regulating site-specific metastasis

Description: Dr. Lisa Sevenich Memorial Sloan Kettering Cancer Center, New York

10.04.2014 - 15:30h

Natural killer cells and leukemia: Role of KIR and HLA class I ligands

Description: Prof. Dr. Markus Uhrberg
Klinikum der Heinrich Heine Universität Düsseldorf

03.04.2014 - 15:30h

Jüdische Wissenschaftler an den Frankfurter Instituten im "Dritten Reich"

Description: Dr. Klaus Cussler

31.03.2014 - 15:00h

Mechanistic Underpinnings of Tumor Cell Hormone Responsiveness: Signaling through Estrogen Receptors, eNOS and Hypoxia-Inducible Factors

Description: Dr. Antonella Farsetti National Research Council (CNR-IBCN) and Regina Elena Cancer Institute, Rome, Italy 

20.03.2014 - 15:30h

Gastro-intestinal stem cells in homeostasis and tumor initiation

Description: Dr. Daniel Stange 
Universitätsklinikum Dresden

23.01.2014 - 15:30h

Towards a therapeutic RNA world

Description: Prof. Dr. Ugur Sahin
TRON Translationale Onkologie an der Universitätsmedizin Mainz

10.12.2013 - 15:30h

Cytokines and tumor elicited inflammation in colorectal cancer

Description: Sergei Grivennikov, Ph.D., Assistant Professor, Fox Chase Cancer Center

25.11.2013 - 16:00h

RNAi and mouse models to study GI tumors

Description: Prof. Dr. Lars Zender Universitätsklinikum Tübingen

21.11.2013 - 15:30h

Extracellular vesicle signaling in the tumor microenvironment and between tissues

Description: Dr. Stefan Momma Universitätsklinikum Frankfurt

31.10.2013 - 15:30h

Cell death driven infections in human phagocytes

Description: Dr. Ger Zandbergen
Paul-Ehrlich-Institut, Langen

26.09.2013 - 15:30h

Targeting inflammation-associated gastric cancer

Description: Moritz Eißmann
Walter & Eliza Hall Institute of Medical Research
Parkville, Australia

06.06.2013 - 09:00h

Jahrestagung BMBF Verbünde "Seltene Erkrankungen"

Description: kein Gastseminar

16.05.2013 - 15:30h

Proteolytic EGF ligand release: Novel strategies for targeted inhibition

Description: Prof. Dr. Andreas Herrlich
Harvard Medical School
Boston, USA

02.05.2013 - 15:30h

Biogenic compounds as valuable leads and tools in inflammation research

Description: Prof. Dr. Robert Fürst
Institut für Pharmazeutische Biologie
Goethe-Universität Frankfurt

18.04.2013 - 15:30h

Epigenetic mechanisms in development

Description: Prof. Dr. Jörn Walter
Universität des Saarlandes

11.04.2013 - 15:30h

Treg-mediated control of dendritic cell function

Description: Prof. Dr. Hansjörg Schild
Institute for Immunology
University Medical Center Mainz

27.03.2013 - 15:30h

Epigenetic drug discovery: probing the bookmarks of life

Description: Prof. Dr. Manfred Jung

21.03.2013 - 15:30h

Molecular & epigenetic mechanisms of MLL protein in acute leukaemia

Description: Prof. Dr. Tom Milne
University of Oxford

07.03.2013 - 08:00h

kein Gastvortrag

Description: Winterschule des GK 1172

28.02.2013 - 15:30h

OmniRat und OmniMouse: A new fully human antibody platform

Description: Dr. Roland Buelow
Palo Alto

21.02.2013 - 15:30h

Tumor targeting with designed proteins

Description: Prof. Dr. Andreas Plückthun
Universität Zürich

14.02.2013 - 15:30h

Melanoma Stem Cells: Biology and Therapeutic Implications

Description: Dr. Thomas Schatton
Harvard Medical School
Boston, USA

07.02.2013 - 15:30h

Generation of designer T cells for immunotherapy of cancer

Description: Prof. Dr. Wolfgang Uckert
MDC Berlin

31.01.2013 - 15:30h

Nucleic acid sensing by the innate immune system

Description: Prof. Dr. Veit Hornung
Institut für Klinische Chemie und Pharmakologie
Universitätsklinikum Bonn

23.01.2013 - 15:30h

Titel wird noch bekannt gegeben

Prof. Dr. Ugur Sahin, TRON Translationale Onkologie an der Universitätsmedizin Mainz

10.01.2013 - 15:30h

Human gamma-delta- T-cells: crosstalk between innate and adaptive immunity

Description: Prof. Dr. med. Dieter Kabelitz
Institut für Immunologie
Universität Kiel

05.12.2012 - 15:30h

Dr. David Levens "Making Myc Simple: Myc as a universal amplifier of gene expression"

Description: Dr. David Levens
NIH Bethesda, USA

04.12.2012 - 15:00h

Vortrag fällt aus! Prof. Dr. med. Wilfried Roth "Mechanismen des Zelltodes in der Tumorpathologie"

Description: Prof. Dr. med. Wilfried Roth
Institut für Pathologie der
Universität Heidelberg
und DKFZ

15.11.2012 - 15:30h

C/EBPdelta: Dr. Jekyll and Mr. Hyde in breast cancer biology through opposing functions in epithelial and immune cells

Description: Dr. Esta Sterneck
National Institutes of Health
Bethesda, USA

08.11.2012 - 15:30h

Intrinsic immunity & lentiviral countermeasures

Description: Prof. Dr. Oliver Keppler
Institut für Medizinische Mikrobiologie
Goethe-Universität Frankfurt

01.11.2012 - 15:30h

Dr. Claudia Waskow "Opening up the niche for human and mouse hematopoietic stem cells"

Description: Dr. Claudia Waskow
DFG Center for Regenerative Therapies
Regeneration in Hematopoiesis
TU Dresden

11.10.2012 - 15:30h

Dr. Pablo Menéndes Bujàn “Towards the development of human stem cell-based-models to reproduce the infant MLL-AF4+ B-Acute Lymphoblastic Leukemia”

Description: Dr. Pablo Menéndez Buján
Pfizer - Universidad de Granada
Granada, Spain

20.09.2012 - 15:30h

Dr. Jan Paul Medema "Cancer stem cells, Wnt signaling and cinical reality in colon cancer"

Description: Dr. Jan Paul Medema
Center for Experimental Molecular Medicine
Academic Medical Center

13.09.2012 - 15:30h

Prof. Oliver Keppler VERSCHOBEN AUF 8. NOVEMBER 2012

Description: Prof. Dr. Oliver Keppler
Institut für Medizinische Mikrobiologie
Goethe-Universität Frankfurt

28.08.2012 - 15:30h

Cell hierarchy and lineage commitment in the bovine mammary gland

Description: Prof. Dr. Itamar Barash
Institute of Animal Science
The Volcani Center
Bet-Dagan, Israel

02.08.2012 - 15:30h

Next generation sequencing in oncology research and diagnostics

Description: PD Dr. Ekkehard Schütz
Chronix Biomedical and
Georg August University Göttingen

12.07.2012 - 15:30h

Teaching an old enzyme a new trick: A novel in vivo chemoselection strategy for hematopoietic stem cell transplantation

Description: Dr. Katrin Hacke
University of California
Los Angeles

14.06.2012 - 15:30h

How to stick, kill and let go without getting hurt - daily problems of a killer

Description: Dr. Carsten Watzl
Leibniz Research Centre for Working Environment and Human Factors - IfADo

31.05.2012 - 15:30h

Applying RNAi to functional genomics in lymphoma

Description: Dr. Cornelius Miething
Memorial Sloan Kettering Cancer Center

03.05.2012 - 15:30h

The power of DNA double-strand break (DSB) repair testing to predict breast cancer

Description: Prof. Lisa Wiesmüller
Universität Ulm

23.04.2012 - 15:30h

The role of mitochondria and iron-sulfur protein biogenesis in DNA damage repair and genomic stability

Description: Dr. Oliver Stehling
Universität Marburg

08.03.2012 - 15:30h

Lead Discovery Center (LDC) – Bridging the 'Innovation Gap

Description: Dr. Bert Klebl
Dr. Peter Nussbaumer
Lead Discovery Center GmbH

23.02.2012 - 15:30h

Type I interference in viral infection and beyond

Description: PD Dr. Zoé Waibler

16.02.2012 - 15:30h

Blood vessels in tumor and fat: a common target for therapy

Description: Prof. Dr. Yihai Cao
Karolinska Institute

19.01.2012 - 14:00h

Sleeping Beauty Minisymposium

28.11.2011 - 14:00h

Öffentliche Anhörung der Bewerber/innen der Vorauswahl für die Professur (W3) für Reprogrammierung am GSH im Rahmen des LOEWE-Zentrums für Zell- und Gentherapie

Description: PD Dr. Frank Edenhofer
Institut für Rekonstruktive Neurobiologie, Universität Bonn
"Omnis cellula e cellula - Neue Wege der Reprogrammierung von Zellen"
PD Dr. Guido Posern
Max-Planck-Institut für Biochemie,

25.11.2011 - 14:00h

Öffentliche Anhörung der Bewerber/innen der Vorauswahl für die Professur (W2) für Zell- und Gentherapie am GSH im Rahmen des LOEWE-Zentrums für Zell- und Gentherapie

Description: Dr. Benedikt Berninger
Helmholtz-Zentrum München, German Research Center for Environment and Health
"Direct conversion of pericyte-derived cells of the adult brain into functional neurons"
PD Dr. Hildegard Büning

24.11.2011 - 15:30h

Bartonella henselae: adhesins, infection and angiogenesis

Description: Prof. Dr. Volkhard Kempf
Institut für Med. Mikrobiologie
und Krankenhaushygiene
Klinikum der Goethe-Universität

21.11.2011 - 10:00h

Mini-Symposium in Tumor Biology

Description: Dr. Matthias Drosten
Centro Nacional de Investigaciones Oncológicas, Madrid
"Critical aspects of Ras-signalling"
Dr. Anette Duensing
University of Pittsburgh Cancer Institute
"Oncogenic kinases a

17.11.2011 - 15:30h

Generation of murine haploid embryonic stem cells as a novel tool for functional genomics

Description: Dr. Ulrich Elling
IMBA - Institute for Molecular Biotechnology
Wien, Österreich

10.11.2011 - 15:30h

Function of Gfi1 in leukemia

Description: Dr. Cyrus Khandanpour
Universität Essen

03.11.2011 - 15:30h

A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphoma genesis

Description: Dr. Tobias Berg
Dept. of Hematology
Universitätsklinikum Frankfurt

24.10.2011 - 17:00h

Targeting the Self-Renewal Function of Normal and Leukemic Hematopoietic Stem Cells

Description: Prof. Dr. Keith Humphries
Terry Fox Laboratory
Vancouver, Canada

20.10.2011 - 09:00h

Symposium: "Cytokine receptors and their Stat mediated mechanisms of action"

Description: Sprecher:
Prof. Dr. Bernd Groner
Georg-Speyer-Haus, Frankfurt
Introduction: "Signal transducers and activators of transcription"
Prof. Dr. Lothar Hennighausen
NDDK, National Institutes of Health, Bethesd

06.10.2011 - 14:00h

Workshop Stem Cells

Description: Kein Gastvortrag wg. Workshop

15.09.2011 - 15:30h

Development and function of innate lymphoid cells

Description: Prof. Dr. Andreas Diefenbach
Universitätsklinikum Freiburg

12.09.2011 - 15:30h

Autocrine and paracrine components in the modulation of cell proliferation, survival and motility by c-Myc

Description: Dr. Ingram Iaccarino
Institute of Genetics and Biophysics (IGB)
CNR, Naples, Italy

26.08.2011 - 13:00h

Symposium zum Paul-Ehrlich und Ludwig-Darmstädter-Nachwuchspreis

Description: Sprecher:
Prof. Dr. Florian Greten
Klinikum rechts der Isar, München
"Molecular analysis of inflammatory pathways during tumor initiation and progresssion"

Dr. Kathrin Maedler
Universität Bremen

22.07.2011 - 14:00h

The O6-alkylguanine response: implications for glioma and melanoma therapy

Description: Prof. Dr. Bernd Kaina
Institut für Toxikologie
Universität Mainz

21.07.2011 - 15:30h

From genotype to phenotype: accessing information about mouse mutants for the study of mammalian gene function and human disease

Description: Dr. Martin Ringwald
The Jackson Laboratory
Bar Harbor, USA

30.06.2011 - 11:00h

Titel werden noch bekannt gegeben

Description: Vorträge der Bewerber für die W3-Professur Tumorbiologie im GSH (Nachfolge Prof. Groner)

29.06.2011 - 11:00h

Titel werden noch bekannt gegeben

Description: Vorträge der Bewerber für die W3-Professur Tumorbiologie im GSH (Nachfolge Prof. Groner)

16.06.2011 - 15:30h

Role of the STAT3 oncogene in response to chemotherapy and drug resistance

Description: Prof. Dr. Olivier Coqueret
Paul-Papin Cancer Center
Angers, France

15.06.2011 - 15:30h

DNA damage induced cell cycle alterations: ex vivo concepts, in vivo veritas

Description: Dr. Daniel Speidel
Children's Medical Research Institute
Cell Transformation Unit
Wentworthville, New South Wales

26.05.2011 - 15:30h

Modulation of the ATRA response by EVI1

Description: Prof. Dr. Rotraud Wieser
Medizinische Universität Wien

19.05.2011 - 17:00h

Breast cancer stem cells: therapeutic resistance and novel targets

Description: Prof. Dr. Rober B. Clarke
Paterson Institute for Cancer Research
University of Manchester
Manchester, UK

12.05.2011 - 15:30h

Exploiting genetic vulnerabilities for the treatment of cancer

Description: PD Dr. Christian Reinhardt
Universität Köln
PD Dr. Christian Reinhardt
Universität Köln

05.05.2011 - 15:30h

Systems-biology approaches to unravel RNA virus-host interactions

Description: Dr. Renate König
Paul-Ehrlich-Institut, Langen
Sanford-Burham Medical Research Institute, La Jolla

14.04.2011 - 17:00h

Kinases as central therapeutic targets in malignancies

Description: Prof. Dr. med. Justus Duyster
Klinikum rechts der Isar
TU München

07.04.2011 - 15:30h

Targeted mutagenesis in mammalian zygotes using zinc-finger nucleases

Description: Dr. Ralf Kühn
Institute for Developmental Genetics
Helmholtz Center Munich

31.03.2011 - 15:30h

Genetics of progression and drug resistance in chronic myeloid leukemia

Description: Prof. Dr. Andreas Burchert
Philipps-Universität Marburg

24.03.2011 - 15:30h

Regulation of gene expression: Artificial transcription control and post-transcriptional regulation

Description: Dr. Ulrich Tschulena
Division Molecular Genome Analysis
DKFZ, Heidelberg

10.03.2011 - 09:00h

GRK Winterschule

Description: Veranstaltung des GRK 1172
Kein Gastvortrag

03.03.2011 - 15:30h

Reprogramming Somatic Cells: Protocols, Problems and Usage of induced Pluripotent Stem Cells

Description: Dr. Pierre Debs
Molekulare Hämatologie
Universitätsklinikum Frankfurt

24.02.2011 - 15:30h

Synthetic lethality in the context of oncogenic KRAS

Description: Dr. Claudia Scholl
Universitätsklinikum Ulm

17.02.2011 - 15:30h

Intracellular Immunity: Viral neutralisation inside infected cells

Description: Dr. Leo James
MRC, Cambridge, UK

10.02.2011 - 17:00h

Epigenome profiling provides novel molecular insight into development, differentiation and transformation

Description: Prof. Dr. Henk Stunnenberg
Radboud University Nijmegen Medical Centre

27.01.2011 - 15:30h

Human NK cell responsiveness to target cells - impact of co-stimulation and education

Description: Dr. Cyril Fauriat
Centre de Recherche en Cancérologie de Marseille
Marseille, France

09.12.2010 - 15:30h

Proteins required for centrosome clustering

Description: Prof. Dr. Alwin Krämer
DKFZ und Universitätsklinikum Heidelberg

07.12.2010 - 15:30h

microRNA dependent regulation of mammary gland development

Description: Dr. Ahmet Ucar
MPI für biophysikalische Chemie

02.12.2010 - 15:30h

Molecular Mechanisms of Stem Cell Aging

Description: Prof. Dr. Karl Lenhard Rudolph
Institute of Molecular Medicine and Max-Planck-Research Department on Stem Cell Aging
Universität Ulm

25.11.2010 - 17:00h

Breast cancer stem cells: therapeutic resistance and novel targets

Description: Prof. Dr. Rober B. Clarke
Paterson Institute for Cancer Research
University of Manchester
Manchester, UK

18.11.2010 - 15:30h

Chromatin dynamics and remodeling in differentiation and disease

Description: Prof. Dr. Christina Cardoso
Technische Universität Darmstadt

11.11.2010 - 17:00h

Genetic modification of hematopoietic and pluripotent cells in gene therapy and tumor biology

Description: Prof. Dr. Christopher Baum
Dept. Experimental Oncology
Hannover Medical School

04.11.2010 - 15:30h

Exploiting apoptosis signaling pathways for cancer therapies

Description: Prof. Dr. Simone Fulda
Universitätsklinikum Frankfurt

28.10.2010 - 15:30h

Transgene expression under non-selective growth conditions

Description: Dr. Manfred Gossen
Berlin-Brandenburg Center for Regenerative Therapies

14.10.2010 - 17:00h

Acute Leukemia: transcription factor Gfi1 as biomarker and potential therapeutic target

Description: Prof. Tarik Möröy
Université de Montréal
Montréal, Canada

07.10.2010 - 17:00h

Molecular mechanisms in inflammation and cancer

Description: Dr. med. Florian Greten
Klinikum Rechts der Isar
Technische Universität München

23.09.2010 - 15:30h

Deconstructing the HIV-1C Env: The Neutralizing Mimome

Description: Dr. Michael Humbert
Dana Farber Cancer Institute
Harvard Medical School

09.09.2010 - 17:00h

The search for metastases founder cells

Description: Prof. Dr. Christoph Klein
Universität Regensburg

- To Top -